Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Innovative Pharmaceutical Biotech ( (HK:0399) ).
Innovative Pharmaceutical Biotech Limited announced significant changes in its board of directors effective April 7, 2025. The company has accepted the resignations of Mr. Li Jiehong as executive director and Ms. Jiang Nian as non-executive director, both stepping down to focus on personal business engagements. The board expressed gratitude for their contributions. In their place, Dr. Long Fan and Dr. Wu Ming have been appointed as executive directors, while Dr. Xia Tingkang, Tim, joins as an independent non-executive director. Additionally, Mr. Tang Rong has been appointed to the remuneration committee. These changes are expected to bring fresh perspectives and expertise to the company’s leadership, potentially impacting its strategic direction and stakeholder relations.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical solutions.
YTD Price Performance: -25.48%
Average Trading Volume: 864,611
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$282.4M
Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue